Campbell, M., Kiss, C., Zimmermann, M., Riccheri, C., Kowalczyk, J., Felice, M., Kuzmanovic, M., Kovács, G., Kosmidis, H., Gonzalez, A., Bilic, E., Castillo, L., Kolenova, A., Jazbec, J., Popa, A., Konstantinov, D., Kappelmayer, J., Szczepański, T., Dworzak, M., Basso, G., Buldini, B., Gaipa, G., Marinov, N., Rossi, J., Nagy, A., Gáspár, I., Starý, J., Schrappe, M.: Childhood acute lymphoblastic leukemia: results of the randomized intercontinental trial all IC-BFM 2009.
J. Clin. Oncol. "Accepted by Publisher"2023.

Ghansah, H., Bekéné Debreceni, I., Váróczy, L., Rejtő, L., Lóczi, L., Bagoly, Z., Kappelmayer, J.: Patients with multiple myeloma and monoclonal gammopathy of undetermined significance have variably increased thrombin generation and different sensitivity to the anticoagulant effect of activated protein C.
Thromb. Res. 223 44-52, 2023.

Somodi, L., Bekéné Debreceni, I., Kis, G., Cozzolino, M., Kappelmayer, J., Antal, M., Panyi, G., Bárdos, H., Mutch, N., Muszbek, L.: Activation mechanism dependent surface exposure of cellular factor XIII on activated platelets and platelet microparticles.
J. Thromb. Haemost. 20 (5), 1223-1235, 2022.

Frendl, I., Erdei, A., Zsíros, N., Katkó, M., Galgóczi, E., Németi, Z., Bhattoa, H., Kappelmayer, J., Posta, J., Turchányi, B., Urbán, F., Nagy, E.: Alcohol consumption affects the late endocrine consequences of mild traumatic brain injury.
Neuroendocrinol. Lett. 43 (4), 239-245, 2022.

Deli, T., Tóth, J., Csépes-Ruzicska, L., Török, O., Krasznai, Z., Mosolygó, Á., Kappelmayer, J., Lampé, R.: Az epesavmérés szerepe a súlyos terhességi cholestasis szülészeti ellátásában.
Orv. hetil. 163 (20), 797-805, 2022.

Fagyas, M., Fejes, Z., Sütő, R., Nagy, Z., Székely, B., Pócsi, M., Ivády, G., Bíró, E., Bekő, G., Nagy, A., Kerekes, G., Szentkereszty, Z., Papp, Z., Tóth, A., Kappelmayer, J., Nagy, B.: Circulating ACE2 activity predicts mortality and disease severity in hospitalized COVID-19 patients.
Int. J. Infect. Dis. 115 8-16, 2022.

Bereczki, D., Nagy, B., Kerényi, A., Nagy, G., Szarka, K., Kristóf, K., Szalay, B., Vásárhelyi, B., Bhattoa, H., Kappelmayer, J.: EDTA-Induced Pseudothrombocytopenia Up to 9 Months After Initial COVID-19 Infection Associated with Persistent Anti-SARS-CoV-2 IgM/IgG Seropositivity.
Lab. Med. 53 (2), 206-209, 2022.

Illési, Á., Bekéné Debreceni, I., Fejes, Z., Nagy, B., Hódosi, K., Kappelmayer, J., Csanádi, Z., Szűk, T.: Effect of invasive therapeutic coronary interventions on endothelial cell activation and thrombin generation in patients with chronic total coronary occlusion.
Thromb. Res. 217 64-72, 2022.

Kappelmayer, J.: Issue highlights - November 2022.
Cytom. Part B-Clin. Cytom. 102 (6), 425-426, 2022.

Szabó, G., Antal-Szalmás, P., Kerényi, A., Pénzes-Daku, K., Bécsi, B., Kappelmayer, J.: Laboratory Approaches to Test the Function of Antiphospholipid Antibodies.
Semin. Thromb. Hemost. 48 (2), 132-144, 2022.

Molnár, C., Gál, J., Szántó, D., Fülöp, L., Szegedi, A., Siró, P., Nagy, E., Lengyel, S., Kappelmayer, J., Fülesdi, B.: Takotsubo cardiomyopathy in patients suffering from acute non-traumatic subarachnoid hemorrhage: A single center follow-up study.
PLoS One. 17 (5), 1-20, 2022.

Fagyas, M., Nagy, B., Ráduly, A., Mányiné Siket, I., Mártha, L., Erdősi, G., Sipka, S., Enyedi, E., Szabó, A., Pólik, Z., Kappelmayer, J., Papp, Z., Borbély, A., Szabó, T., Balla, J., Balla, G., Bai, P., Bácsi, A., Tóth, A.: The majority of severe COVID-19 patients develop anti-cardiac autoantibodies.
GeroScience. 44 2347-2360, 2022.

László, I., Berhés, M., Tisza, K., Miltényi, Z., Balázsfalvi, N., Vaskó, A., Asztalos, L., Kertész, A., Fábián, Á., Kappelmayer, J., Fülesdi, B.: The prognostic value of laboratory parameters referring to hemopoietic stress in patients with COVID-19: a single center experience.
Signa Vitae. [Epub ahead of print]2022.

Nagy, B., Fejes, Z., Szentkereszty, Z., Sütő, R., Várkonyi, I., Ajzner, É., Kappelmayer, J., Papp, Z., Tóth, A., Fagyas, M.: A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient.
Int. J. Infect. Dis. 103 412-414, 2021.

Maurer-Granofszky, M., Schumich, A., Buldini, B., Gaipa, G., Kappelmayer, J., Mejstříková, E., Karawajew, L., Rossi, J., Suzan, A., Agriello, E., Anastasiou-Grenzelia, T., Barcala, V., Barna, G., Batinic, D., Bourquin, J., Brüggemann, M., Bukowska-Strakova, K., Burnusuzov, H., Carelli, D., Deniz, G., Dubravčić, K., Feuerstein, T., Gaillard, M., Galeano, A., Giordano, H., Gonzalez, A., Groeneveld-Krentz, S., Hevessy, Z., Hrušák, O., Iarossi, M., Jáksó, P., Kloboves Prevodnik, V., Kohlscheen, S., Kreminska, E., Maglia, O., Malusardi, C., Marinov, N., Martin, B., Möller, C., Nikulshin, S., Palazzi, J., Paterakis, G., Popov, A., Ratei, R., Rodríguez, C., Sajaroff, E., Sala, S., Samardzija, G., Sartor, M., Scarparo, P., Sędek, Ł., Slavkovic, B., Solari, L., Svec, P., Szczepański, T., Taparkou, A., Torrebadell, M., Tzanoudaki, M., Varotto, E., Vernitsky, H., Attarbaschi, A., Schrappe, M., Conter, V., Biondi, A., Felice, M., Campbell, M., Kiss, C., Basso, G., Dworzak, M., I-BFM-FLOW-Network: An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: an I-BFM-FLOW-Network Report.
Cancers (Basel). 13 (23), 1-16, 2021.

Kárai, B., Tisza, K., Eperjesi, O., Nagy, A., Ujfalusi, A., Kelemen, Á., Szegedi, I., Kiss, C., Kappelmayer, J., Hevessy, Z.: A Novel Method for the Evaluation of Bone Marrow Samples from Patients with Pediatric B-Cell Acute Lymphoblastic Leukemia: multidimensional Flow Cytometry.
Cancers (Basel). 13 (20), 1-14, 2021.

Kappelmayer, J., Bhattoa, H., Kovács, G.: An overview on the scientometric advancement of the eJIFCC.
EJIFCC. 32 (4), 403-408, 2021.

Szabó, G., Bekéné Debreceni, I., Tarr, T., Soltész, P., Osterud, B., Kappelmayer, J.: Anti-[beta]2-glycoprotein I autoantibodies influence thrombin generation parameters via various mechanisms.
Thromb. Res. 197 124-131, 2021.

Kappelmayer, J., Tóth, J., Oláh, A.: Módszertani változások a lipidparaméterek meghatározásában a XXI. században.
Metabolizmus. 19 34-39, 2021.

Szilágyi, B., Fejes, Z., Rusznyák, Á., Fenyvesi, F., Pócsi, M., Halmi, S., Griger, Z., Kunapuli, S., Kappelmayer, J., Nagy, B.: Platelet Microparticles Enriched in miR-223 Reduce ICAM-1-Dependent Vascular Inflammation in Septic Conditions.
Front. Physiol. 12 1-14, 2021.

Mezei, G., Batár, P., Kozma, L., Illés, Á., Kappelmayer, J., Bekéné Debreceni, I.: Ponatinib Exerts an Inhibitory Effect on Collagen-induced Platelet Aggregation and Generation of Coated-Platelets.
Anticancer Res. 41 (10), 4867-4874, 2021.

Fejes, Z., Pócsi, M., Takai, J., Erdei, J., Tóth, A., Balogh, E., Rusznyák, Á., Fenyvesi, F., Nagy, A., Kappelmayer, J., Jeney, V., Nagy, B.: Preterm Intraventricular Hemorrhage-Induced Inflammatory Response in Human Choroid Plexus Epithelial Cells.
Int. J. Mol. Sci. 22 (16), 1-20, 2021.

Gindele, R., Kerényi, A., Kállai, J., Pfliegler, G., Schlammadinger, Á., Szegedi, I., Major, T., Szabó, Z., Bagoly, Z., Kiss, C., Kappelmayer, J., Bereczky, Z.: Resolving Differential Diagnostic Problems in von Willebrand Disease, in Fibrinogen Disorders, in Prekallikrein Deficiency and in Hereditary Hemorrhagic Telangiectasia by Next-Generation Sequencing.
Life (Basel). 11 (3), 1-23, 2021.

Ghansah, H., Bekéné Debreceni, I., Fejes, Z., Nagy, B., Kappelmayer, J.: The Proteasome Inhibitor Bortezomib Induces Apoptosis and Activation in Gel-Filtered Human Platelets.
Int. J. Mol. Sci. 22 (16), 1-13, 2021.

Nagy, G., Csípő, I., Tarr, T., Szűcs, G., Szántó, A., Bubán, T., Sipeki, N., Szekanecz, Z., Papp, M., Kappelmayer, J., Antal-Szalmás, P.: Anti-neutrophil cytoplasmic antibody testing by indirect immunofluorescence: computer-aided versus conventional microscopic evaluation of routine diagnostic samples from patients with vasculitis or other inflammatory diseases.
Clin. Chim. Acta. 511 117-124, 2020.